Tower Research Capital (TRC)’s Artiva Biotherapeutics, Inc. Common Stock ARTV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$15.2K Buy
10,098
+7,484
+286% +$11.3K ﹤0.01% 3820
2025
Q1
$7.84K Buy
2,614
+1,402
+116% +$4.21K ﹤0.01% 3930
2024
Q4
$12.2K Buy
1,212
+492
+68% +$4.96K ﹤0.01% 3639
2024
Q3
$11.1K Buy
+720
New +$11.1K ﹤0.01% 3692